Create a narrative

Harrow Community

NasdaqGM:HROW Community

1 Narratives written by author
0 Comments on narratives written by author
9 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 8 Analysts

Expanding Ophthalmic Pipeline Will Capture Dry Eye Opportunity

Key Takeaways Rapid growth in eye care prescriptions, product innovation, and successful market access initiatives are driving higher revenues, margins, and expanding customer reach. Investments in sales infrastructure and digital health, along with strong industry relationships, support sustainable earnings and position the company for scalable long-term growth.

US$59.40

FV

37.3% undervalued

41.85%

Revenue growth p.a.

0

0

6

1 day ago